PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of NanoEngineering, University of California San Diego, La Jolla, CA, USA.\', \'Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.\', \'Pro-SPR GmbH, Alsdorf, Germany.\', \'Center for Nano-ImmunoEngineering, University of California San Diego, La Jolla, CA, USA.\', \'Institute for Materials Discovery and Design, University of California San Diego, La Jolla, CA, USA.\', \'Department of NanoEngineering, University of California San Diego, La Jolla, CA, USA. nsteinmetz@ucsd.edu.\', \'Department of Bioengineering, University of California San Diego, La Jolla, CA, USA. nsteinmetz@ucsd.edu.\', \'Center for Nano-ImmunoEngineering, University of California San Diego, La Jolla, CA, USA. nsteinmetz@ucsd.edu.\', \'Institute for Materials Discovery and Design, University of California San Diego, La Jolla, CA, USA. nsteinmetz@ucsd.edu.\', \'Department of Radiology, University of California San Diego, La Jolla, CA, USA. nsteinmetz@ucsd.edu.\', \'Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. nsteinmetz@ucsd.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41565-020-0737-y
?:hasPublicationType
?:journal
  • Nature nanotechnology
is ?:pmid of
?:pmid
?:pmid
  • 32669664
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 20.612
?:rankingScore_hIndex
  • 263
?:title
  • COVID-19 vaccine development and a potential nanomaterial path forward.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all